Abby Bronson

Abby Bronson, MBA, joined Edgewise Therapeutics in April 2020 as our Vice President of Patient Advocacy and External Innovation. Abby has recent experience as the SVP of Research Strategy at Parent Project Muscular Dystrophy where she managed the research portfolio and developed novel trial strategies to accelerate the clinical trial process in Duchenne. Prior to PPMD she was the Director of Operations at the Division of Clinical Innovation at NCATS, NIH. She has also had senior positions at MedImmune and Children’s National Medical Center. She holds an MBA from the Wharton School of Business at the University of Pennsylvania and a BA from the University of Vermont.